Home

egyetértés Érdeklődés Regényíró counter screen assay reakció Vesuviushegy harag

High-throughput screening against protein:protein interaction interfaces  reveals anti-cancer therapeutics as potent modulators of the voltage-gated  Na+ channel complex | Scientific Reports
High-throughput screening against protein:protein interaction interfaces reveals anti-cancer therapeutics as potent modulators of the voltage-gated Na+ channel complex | Scientific Reports

ASSAY DEVELOPMENT IN DRUG DISCOVERY
ASSAY DEVELOPMENT IN DRUG DISCOVERY

Creating and screening natural product libraries - Natural Product Reports  (RSC Publishing) DOI:10.1039/C9NP00068B
Creating and screening natural product libraries - Natural Product Reports (RSC Publishing) DOI:10.1039/C9NP00068B

ASSAY DEVELOPMENT IN DRUG DISCOVERY
ASSAY DEVELOPMENT IN DRUG DISCOVERY

Statistical practice in high-throughput screening data analysis | Nature  Biotechnology
Statistical practice in high-throughput screening data analysis | Nature Biotechnology

Dealing with PAINs in a drug discovery CRO - Sygnature Discovery
Dealing with PAINs in a drug discovery CRO - Sygnature Discovery

Identification of activators of human fumarate hydratase by quantitative  high-throughput screening | bioRxiv
Identification of activators of human fumarate hydratase by quantitative high-throughput screening | bioRxiv

PDF] Action plan for hit identification (APHID): KAT6A as a case study. |  Semantic Scholar
PDF] Action plan for hit identification (APHID): KAT6A as a case study. | Semantic Scholar

Figure 10, [Schematic of an antibody-based counter-screen...]. - Assay  Guidance Manual - NCBI Bookshelf
Figure 10, [Schematic of an antibody-based counter-screen...]. - Assay Guidance Manual - NCBI Bookshelf

Quantitative high-throughput screening assays for the discovery and  development of SIRPα-CD47 interaction inhibitors | PLOS ONE
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors | PLOS ONE

ASSAY DEVELOPMENT IN DRUG DISCOVERY
ASSAY DEVELOPMENT IN DRUG DISCOVERY

Characterization of inhibitors with the counter screen assay and... |  Download Scientific Diagram
Characterization of inhibitors with the counter screen assay and... | Download Scientific Diagram

Screen and counter screen protocol followed in virtual screening for... |  Download Scientific Diagram
Screen and counter screen protocol followed in virtual screening for... | Download Scientific Diagram

Figure 2, CID 1245700 was tested across a range of concentrations up to 10  μM in the primary assay and secondary counter screen, up to 25 μM in  mammalian cytotoxicity assays, and
Figure 2, CID 1245700 was tested across a range of concentrations up to 10 μM in the primary assay and secondary counter screen, up to 25 μM in mammalian cytotoxicity assays, and

Quantitative high-throughput screening assays for the discovery and  development of SIRPα-CD47 interaction inhibitors | PLOS ONE
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors | PLOS ONE

Synergy Screening Identifies a Compound That Selectively Enhances the  Antibacterial Activity of Nitric Oxide - Frontiers
Synergy Screening Identifies a Compound That Selectively Enhances the Antibacterial Activity of Nitric Oxide - Frontiers

Cascade Screening Development Services | Sygnature Discovery
Cascade Screening Development Services | Sygnature Discovery

Development of an AlphaLISA protein-protein interaction assay to screen for  re-purposed drugs as targeted disruptors | BMG LABTECH
Development of an AlphaLISA protein-protein interaction assay to screen for re-purposed drugs as targeted disruptors | BMG LABTECH

High throughput screening technologies for ion channels | Acta  Pharmacologica Sinica
High throughput screening technologies for ion channels | Acta Pharmacologica Sinica

HIGH THROUGHPUT SCREENING DONE RIGHT | Multispan, Inc
HIGH THROUGHPUT SCREENING DONE RIGHT | Multispan, Inc

Brief Guide: Experimental Strategies for High-Quality Hit Selection from  Small-Molecule Screening Campaigns - Ina Rothenaigner, Kamyar Hadian, 2021
Brief Guide: Experimental Strategies for High-Quality Hit Selection from Small-Molecule Screening Campaigns - Ina Rothenaigner, Kamyar Hadian, 2021

A Phenotypic Approach for the Identification of New Molecules for Targeted  Protein Degradation Applications - ScienceDirect
A Phenotypic Approach for the Identification of New Molecules for Targeted Protein Degradation Applications - ScienceDirect

Establishing assays and small molecule screening facilities for Drug  discovery programs - European Pharmaceutical Review
Establishing assays and small molecule screening facilities for Drug discovery programs - European Pharmaceutical Review

A High Throughput Screen for RGS Proteins Using Steady State Monitoring of  Free Phosphate Formation | PLOS ONE
A High Throughput Screen for RGS Proteins Using Steady State Monitoring of Free Phosphate Formation | PLOS ONE

Identification of HMGA2 inhibitors by AlphaScreen-based  ultra-high-throughput screening assays | Scientific Reports
Identification of HMGA2 inhibitors by AlphaScreen-based ultra-high-throughput screening assays | Scientific Reports

Orthogonal assays for the identification of inhibitors of the  single-stranded nucleic acid binding protein YB-1 - ScienceDirect
Orthogonal assays for the identification of inhibitors of the single-stranded nucleic acid binding protein YB-1 - ScienceDirect